INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2025, Number 4

Cardiovasc Metab Sci 2025; 36 (4)

The TG/HDL-c index, a marker of atherogenic dyslipidemia, is a significant factor in the contemporary epidemiological profile of Mexico

ABSTRACT

Introduction: obesity/overweight (O/O) is the basis of the leading causes of general mortality in Mexico: ischemic heart disease and type 2 Diabetes Mellitus (2DM). The lipid triad, associated with O/O, is the most common type of dyslipidemia in our country. We analyzed the lipid profiles of a large sample of the contemporary urban population of Mexico City. Material and methods: sixty-eight thousand participants comprised this cohort. The clinical status, reason for the study, and whether the patient was being treated were not recorded. Total Cholesterol (TC), TriGlycerides (TG), and High-Density Lipoprotein cholesterol (HDL-c) levels were measured spectrophotometrically. Low-Density Lipoprotein (LDL-c) and non-HDL levels, and the risk ratios TC/HDL-c, LDL-c/HDL-c, and TG/HDL-c were calculated. The classification criteria were based on ATP III and European guidelines. The mean values and quartile distributions of all lipids and lipoproteins were estimated and stratified by sex. Results: the TC values were above the cut-off. The TG values were significantly higher than this. The HDL-c levels in both sexes remained close to the lower limit. The LDL-c levels were between 100 and 130 mg/dL in both men and women. Non-HDL-c levels never reached a cut-off of 160 mg/dL. The LDL-c/HDL-c index was below it. Interestingly, the TG/HDL-c values were above the cut-off limit. Conclusions: hypertriglyceridemia, caused by abdominal obesity, is the most critical lipid abnormality in the Mexican population. TG/HDL-c is a readily available, inexpensive risk marker that should be used routinely.
  FULL TEXT PDF   FLIPBOOK

Keywords

hypertriglyceridemia TG/HDL index Mexican society lipid profile




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Uncertainty and probability are the basis of clinical epidemiology
    2025, Vol.36, Núm. 4
  • Initial experience with near-infrared spectroscopy in the treatment of coronary...
    2025, Vol.36, Núm. 4
  • Protocol for certifying stadiums in Mexico as cardio-protected spaces in the...
    2025, Vol.36, Núm. 4
  • Cardioprotected spaces in Mexico: in theory a priority public health issue, but...
    2025, Vol.36, Núm. 4
  • The TG/HDL-c index, a marker of atherogenic dyslipidemia, is a significant...
    2025, Vol.36, Núm. 4
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 36, Num. 4, Octubre-Diciembre 2025. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 8 de octubre de 2025.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/